144 related articles for article (PubMed ID: 6204471)
1. [Choleragen-anatoxin chemical cholera vaccine enriched with Ogawa O-antigen].
Dzhaparidze MN; Nikitina GP; Kulikova VL; Popov AA; Naumov AV
Zh Mikrobiol Epidemiol Immunobiol; 1984 Apr; (4):70-4. PubMed ID: 6204471
[TBL] [Abstract][Full Text] [Related]
2. [The characteristics of the reactogenicity and immunological activity of a new cholera bivalent chemical vaccine based on the results of controlled trials].
Sumarokov AA; Ivanov NR; Dzhaparidze MN; Rystsova EA; Reznikov IuB; Matusevich LIa; Nikitina GP; Eliseev IuIu; Adamova GV; Plotnikova MN
Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):55-8. PubMed ID: 1719716
[TBL] [Abstract][Full Text] [Related]
3. [The population composition of cultures of Vibrio cholerae strain 569 B Pakistan in relation to the manufacture of a cholera vaccine (choleragen-anatoxin+O-antigen)].
Lobanov VV; Nechetskaia RM; Adamova GV
Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):73-6. PubMed ID: 2461623
[TBL] [Abstract][Full Text] [Related]
4. [Oral chemical vaccine made from a toxigenic strain of V. cholerae, Ogawa serovar (an experimental study)].
Dzhaparidze MN; Karaeva LT; Sumarokov AA; Pavlova LP; Marchuk LM
Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):62-8. PubMed ID: 506602
[No Abstract] [Full Text] [Related]
5. [The use of a new strain of Vibrio cholerae O139 as a producer of an enteric chemical vaccine].
Dzhaparidze MN; Naumov AV; Gromova OV; Adamov AK; Eliseev IuIu; Kosmoenko OM; Kuz'michenko IA; Kopyrzov VN; Zavorotnykh VI; Zakharova TL; Chekhovskaia GV
Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):52-5. PubMed ID: 8701657
[TBL] [Abstract][Full Text] [Related]
6. [Biochemical and immunochemical characteristics of a new oral, chemical cholera bivalent vaccine and results of a trial of the preparation on volunteers].
Dzhaparidze MN; Nikitina GP; Ivanov NR; Rystsova EA; Udalova IB
Zh Mikrobiol Epidemiol Immunobiol; 1982; (11):29-33. PubMed ID: 6760628
[TBL] [Abstract][Full Text] [Related]
7. [Comparative analysis of the major protective antigens production in Vibrio cholerae recombinant and producer strains of the classical biovar].
Toporkov AV; Zadnova SP; Smirnova NI
Zh Mikrobiol Epidemiol Immunobiol; 2005; (1):53-7. PubMed ID: 15773401
[TBL] [Abstract][Full Text] [Related]
8. [An oral chemical vaccine from the hypertoxigenic strains of the causative agent of cholera KM-76 Inaba and KM-68 Ogawa].
Dzhaparidze MN; Naumov AV; Nikitina GP; Meleshchenko MV; Dobrova GV; Zavorotnykh VI; Gracheva VP; Zakharova TL
Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):31-3. PubMed ID: 1882603
[TBL] [Abstract][Full Text] [Related]
9. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
[TBL] [Abstract][Full Text] [Related]
10. [The determination of the optimal inoculation dose of an oral cholera chemical bivalent vaccine in a controlled experiment].
Sumarokov AA; Ivanov NR; Dzhaparidze MN; Reznikov IuB; Rystsova EA; Nikitina GP; Matusevich LIa; Popov AA; Plotnikova MN; Shustov VIa
Zh Mikrobiol Epidemiol Immunobiol; 1990 Dec; (12):55-62. PubMed ID: 2099071
[TBL] [Abstract][Full Text] [Related]
11. [Isolation and phenotyping of Vibrio cholerae strains with the enhanced production of main protective antigens].
Zadnova SP; Toporkov AV; Smirnova NI
Zh Mikrobiol Epidemiol Immunobiol; 2001; (2):3-6. PubMed ID: 11548254
[TBL] [Abstract][Full Text] [Related]
12. Immunological responses of rabbits to various somatic and secreted antigens of Vibrio cholerae after intra-duodenal inoculation.
Kabir S
J Med Microbiol; 1987 Aug; 24(1):29-40. PubMed ID: 3612742
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and expression in Escherichia coli K-12 of the O antigens of the Inaba and Ogawa serotypes of the Vibrio cholerae O1 lipopolysaccharides and their potential for vaccine development.
Manning PA; Heuzenroeder MW; Yeadon J; Leavesley DI; Reeves PR; Rowley D
Infect Immun; 1986 Aug; 53(2):272-7. PubMed ID: 2426198
[TBL] [Abstract][Full Text] [Related]
14. Infection and immunity to Vibrio cholerae, Salmonella typhimurium and Escherichia coli in a rabbit model.
Guinée PA; Jansen WH; Rijpkema SG
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):260-9. PubMed ID: 2464884
[TBL] [Abstract][Full Text] [Related]
15. Protection in rabbits induced by the Texas Star-SR attenuated A-B+ mutant candidate live oral cholera vaccine.
Boesman-Finkelstein M; Finkelstein RA
Infect Immun; 1982 Apr; 36(1):221-6. PubMed ID: 7076295
[TBL] [Abstract][Full Text] [Related]
16. [Reactogenicity and immunological effectiveness of a chemical sorbed typhoid vaccine in combination with choleragen-anatoxin administered subcutaneously by jet injector].
Gapochko KG; Emel'ianova OV; Konovalov SI; Mokrousov VB; Ttiova TS
Zh Mikrobiol Epidemiol Immunobiol; 1984 Feb; (2):95-7. PubMed ID: 6711201
[TBL] [Abstract][Full Text] [Related]
17. [2-cycle culture of Vibrio cholerae in a fermenter].
Nenkov PKh; Strashimirova N; Polikar ACh
Zh Mikrobiol Epidemiol Immunobiol; 1986 Jul; (7):21-4. PubMed ID: 3529759
[TBL] [Abstract][Full Text] [Related]
18. Antitoxic immunity to cholera in dogs immunized orally with cholera toxin.
Pierce NF; Cray WC; Engel PF
Infect Immun; 1980 Feb; 27(2):632-7. PubMed ID: 7380543
[TBL] [Abstract][Full Text] [Related]
19. [Strains of Vibrio cholerae serogroups O1 and O139 that produce the basic protective antigens].
Smirnova NI; Livanova LF; Chekhovskaia GV; Eroshenko GA; Lazovskiĭ IuV; Zakharova TL
Zh Mikrobiol Epidemiol Immunobiol; 2000; (3):47-51. PubMed ID: 10925874
[TBL] [Abstract][Full Text] [Related]
20. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.
Levine MM; Nalin DR; Craig JP; Hoover D; Bergquist EJ; Waterman D; Holley HP; Hornick RB; Pierce NP; Libonati JP
Trans R Soc Trop Med Hyg; 1979; 73(1):3-9. PubMed ID: 442179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
